Safety and PK Study of MP-424 to Treat Chronic Hepatitis C

NCT00591214 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: MP-424 (Telaprevir)

Sponsor

Tanabe Pharma Corporation

Collaborators

[object Object]